Plain-English translation of NCT05346809 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lymphoma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called given alongside a stem cell transplant procedure. Stem cell transplant is a strong treatment for blood cancers like multiple myeloma and lymphoma, but patients sometimes relapse afterward. Researchers believe that , which works by targeting immune cells, might help your body's immune system work better after transplant and reduce the chance of the cancer coming back.
Cancer often returns after stem cell transplant because the immune system needs time to rebuild and may not be strong enough to control remaining cancer cells. This trial explores whether adding this medication during transplant can improve how well your immune system recovers and prevent relapse.
If you join this study, you would receive the standard stem cell transplant procedure, but half of participants will also receive the experimental medication during the transplant process while the other half receive standard treatment alone. The study involves about 39 people total, and you would be monitored to see how your immune system recovers after transplant and whether your cancer returns.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States